May is Melanoma Awareness Month!

Click here to learn about the awareness campaigns, educational programs, contests and activities happening this month – and meet the 2022 #GetNaked spokespeople!





The MRF is at ASCO!

The MRF is proud to join the American Society of Clinical Oncology (ASCO) Annual Meeting on June 3-7, 2022 in Chicago, IL. If you are attending ASCO in person, make sure to visit Booth #5027 to meet our team! This year’s meeting also has free virtual participation options for those who want to attend remotely.


New FDA Treatment Approvals


New FDA Treatment Approvals

The US Food and Drug Administration recently granted two approvals to advance the development of new melanoma treatments. Click here to learn more!




What is TIL Therapy?

NEW: Check out the latest animated video in the MRF Education Institute to learn more about tumor infiltrating lymphocyte (TIL) therapy, how it is used to treat melanoma and which patients may benefit from this form of treatment.

Ocular Melanoma

Ocular Melanoma Patients: Register Today!

Ocular Melanoma

Ocular Melanoma Patients: Register Today!

Join the first patient-powered, patient-reported ocular melanoma patient registry and help us find a cure!




Attend a Patient Symposium

Learn from leaders in melanoma research and treatment while networking with other patients and caregivers. Click here to see upcoming meetings and register today!

The MRF’s mission is to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community.

Melanoma is the deadliest form of skin cancer.

Melanoma claims the lives of over 7,000 Americans every year.

Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.

9 out of 10 cases are considered to be preventable.

Funding Melanoma Research

Funding from The MRF has resulted in:

clinical trials

25 Clinical trials


109 Grants with new collaborations


236 Publications


484 Presentations

Recent Funded Research Recipients

Melanoma Risks and Risk Prediction in Patients with Actinic Keratosis
Therapeutic Resistance to CDK4/6 inhibitors in BRAF-mutant Melanoma
Targeted intervention of melanoma by reprogramming the stromal translatome
Control of Anti-Tumor Response by the Modulation of Neurotransmitter-Expressing Immune Cells

Latest News

Friday before Memorial Day Declared “Don’t Fry Day” as Reminder to Take Small Steps for Sun Safety Washington, DC –
Guest blog from Amy Nichole, who shares her story as a three-time melanoma survivor and reflects on her journey with
Memphis, TN (May 26, 2022) - The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its
Guest blog from Candice Mason, who shares her story with stage IV melanoma and how she gives back to the

Optimize Your Treatment

Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients?

Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.


Shop to Support MRF.

Grab some merch to support our mission to eradicate melanoma by accelerating medical research while educating to and advocating for the melanoma community.




The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.